Showing results (31-40 of 321) with videos related to

Sort By:
Pageof 33
The Western Journal of Emergency Medicine|April 29, 2026
Cross-Sectional Examination of Hospital Visits in the Year Prior to Suicide Death in IllinoisMaryann Mason, Yingxuan Liu, Krina Patel, et al.
Haematologica|January 12, 2005
Factors predicting molecular and cytogenetic response in chronic myeloid leukemia patients treated with imatinibCatherine Roche-Lestienne, Stéphane Darré, Jean-Luc Laï, et al.
Presse Medicale (Paris, France : 1983)|August 27, 2019
[Multiple myeloma: New criteria for diagnosis and treatment, strong therapeutic hopes]Salomon Manier, Marie de Charette de la Contrie, Julia Hieulle, et al.
Blood Reviews|February 8, 2022
Current state and next-generation CAR-T cells in multiple myelomaSalomon Manier, Tiziano Ingegnere, Guillaume Escure, et al.
Cureus|October 14, 2024
Implementing the Debriefing Assessment for Simulation in Healthcare (DASH) Tool for Training Medical FacultyThura Al-Khayat, Stefanie Carter, McHenry Mauger, et al.
Case Reports in Cardiology|February 23, 2026
When the Healthcare System Breaks a Heart: A Case of Stress Cardiomyopathy Following a Conversation With an Insurance ProviderKramer J Wahlberg, Friederike K Keating, Salmaan Mumtaz, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2024
Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert RoundtableSikander Ailawadhi, Leyla Shune, Sandy W Wong, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2021
Association of Morbid Progression With Overall Survival Among Patients With Multiple Myeloma: Validation of the Progression-free Survival EndpointAaron S Rosenberg, Thierry Facon, Kejal Parikh, et al.
Blood Advances|August 5, 2021
Effective anti-BCMA retreatment in multiple myelomaNicolas Gazeau, David Beauvais, Ibrahim Yakoub-Agha, et al.
Pageof 33